RAJENDRA KOIRALA: Open Payments
NPI 1952588972 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 88 payments from 15 companies in 2025. Trend: 2023 $1,886 · 2024 $2,494 · 2025 $1,890
Food & beverage: $1,890
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 25 | $648 |
| E.R. Squibb & Sons, L.L.C. | 15 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $252 |
| Otsuka America Pharmaceutical, Inc. | 8 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $104 |
| Janssen Pharmaceuticals, Inc | 5 | $98 |
| Neurocrine BioSciences, Inc. | 5 | $88 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $60 |
| Lundbeck LLC | 2 | $46 |
| ABBVIE INC. | 2 | $43 |
Products named: FANAPT, COBENFY, CAPLYTA, REXULTI, TRINTELLIX, SPRAVATO, INGREZZA, VRAYLAR.
Industry payments across OH — which companies pay providers there.
